Back to Search Start Over

Molecular Targeting Agents in Cancer Therapy: Science and Society

Authors :
Asim Jamal Shaikh
Source :
Asian Pacific Journal of Cancer Prevention. 13:1705-1708
Publication Year :
2012
Publisher :
Asian Pacific Organization for Cancer Prevention, 2012.

Abstract

The inception of targeted agents has revolutionized the cancer therapy paradigm, both for physicians and patients. A large number of molecular targeted agents for cancer therapy are currently available for clinical use today. Many more are in making, but there are issues that remain to be resolved for the scientific as well as social community before the recommendation of their widespread use in may clinical scenarios can be done, one such issue being cost and cost effectiveness, others being resistance and lack of sustained efficacy. With the current knowledge about available targeted agents, the growing knowledge of intricate molecular pathways and unfolding of wider spectrum of molecular targets that can really matter in the disease control, calls for only the just use of the agents available now, drug companies need to make a serious attempt to reduce the cost of the agents. Research should focus on agents that show sustained responses in preclinical data. More needs to be done in laboratories and by the pharmaceutical industries, before we can truly claim to have entered a new era of targeted therapy in cancer care.

Details

ISSN :
15137368
Volume :
13
Database :
OpenAIRE
Journal :
Asian Pacific Journal of Cancer Prevention
Accession number :
edsair.doi.dedup.....4f46a129183c95890874688b247244e8
Full Text :
https://doi.org/10.7314/apjcp.2012.13.4.1705